Sahin AA - Search Results

1

Her-2/neu gene amplification in ductal carcinoma in situ of the breast.

Hoque A, Sneige N, Sahin AA, Menter DG, Bacus JW, Hortobagyi GN, Lippman SM. Hoque A, et al. Among authors: sahin aa. Cancer Epidemiol Biomarkers Prev. 2002 Jun;11(6):587-90. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12050101

2

Expression profile of tyrosine kinases in breast cancer.

Meric F, Lee WP, Sahin A, Zhang H, Kung HJ, Hung MC. Meric F, et al. Clin Cancer Res. 2002 Feb;8(2):361-7. Clin Cancer Res. 2002. PMID: 11839650

3

Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.

Half E, Tang XM, Gwyn K, Sahin A, Wathen K, Sinicrope FA. Half E, et al. Cancer Res. 2002 Mar 15;62(6):1676-81. Cancer Res. 2002. PMID: 11912139

4

Multicentric mammary carcinoma: evidence of monoclonal proliferation.

Middleton LP, Vlastos G, Mirza NQ, Eva S, Sahin AA. Middleton LP, et al. Among authors: sahin aa. Cancer. 2002 Apr 1;94(7):1910-6. doi: 10.1002/cncr.10452. Cancer. 2002. PMID: 11932891 Free article.

5

Pseudoangiomatous stromal hyperplasia of the breast.

Castro CY, Whitman GJ, Sahin AA. Castro CY, et al. Among authors: sahin aa. Am J Clin Oncol. 2002 Apr;25(2):213-6. doi: 10.1097/00000421-200204000-00024. Am J Clin Oncol. 2002. PMID: 11943906

6

Axillary lymph node cellular immune response to HER-2/neu peptides in patients with carcinoma of the breast.

Kuerer HM, Peoples GE, Sahin AA, Murray JL, Singletary SE, Castilleja A, Hunt KK, Gershenson DM, Ioannides CG. Kuerer HM, et al. Among authors: sahin aa. J Interferon Cytokine Res. 2002 May;22(5):583-92. doi: 10.1089/10799900252982061. J Interferon Cytokine Res. 2002. PMID: 12060497

7

E-cadherin immunohistochemical analysis of histiocytoid carcinoma of the breast.

Gupta D, Croitoru CM, Ayala AG, Sahin AA, Middleton LP. Gupta D, et al. Among authors: sahin aa. Ann Diagn Pathol. 2002 Jun;6(3):141-7. doi: 10.1053/adpa.2002.33880. Ann Diagn Pathol. 2002. PMID: 12089723

8

Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy.

Buchholz TA, Katz A, Strom EA, McNeese MD, Perkins GH, Hortobagyi GN, Thames HD, Kuerer HM, Singletary SE, Sahin AA, Hunt KK, Buzdar AU, Valero V, Sneige N, Tucker SL. Buchholz TA, et al. Among authors: sahin aa. Int J Radiat Oncol Biol Phys. 2002 Jul 15;53(4):880-8. doi: 10.1016/s0360-3016(02)02850-x. Int J Radiat Oncol Biol Phys. 2002. PMID: 12095553

9

Assessment of histologic features and expression of biomarkers in predicting pathologic response to anthracycline-based neoadjuvant chemotherapy in patients with breast carcinoma.

Wang J, Buchholz TA, Middleton LP, Allred DC, Tucker SL, Kuerer HM, Esteva FJ, Hortobagyi GN, Sahin AA. Wang J, et al. Among authors: sahin aa. Cancer. 2002 Jun 15;94(12):3107-14. doi: 10.1002/cncr.10585. Cancer. 2002. PMID: 12115341 Free article.

10

A naturally occurring MTA1 variant sequesters oestrogen receptor-alpha in the cytoplasm.

Kumar R, Wang RA, Mazumdar A, Talukder AH, Mandal M, Yang Z, Bagheri-Yarmand R, Sahin A, Hortobagyi G, Adam L, Barnes CJ, Vadlamudi RK. Kumar R, et al. Nature. 2002 Aug 8;418(6898):654-7. doi: 10.1038/nature00889. Nature. 2002. PMID: 12167865

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

361 results

Search Page

Filters